Clinical Trial Update: Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Seroquel Extended Release (XR) for Borderline Personality Disorder has been completed. Results were posted on 2016-12-28.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Seroquel Extended Release (XR) (quetiapine)

Snippet

Sponsor: University of Minnesota | Conditions: Borderline Personality Disorder | Phase 3 | Status: COMPLETED | Results posted: 2016-12-28